Tevogen - Warrant (TVGNW) closed at $0.04 on November 13, 2026, down 12.9% from the previous close, on volume of 307,168 shares (30-day average 518,629).
Data as of November 13, 2026.
No headlines found.
Tevogen Complements Capital Access with Two-Year Extension to Loan Agreement
Globe Newswire (Mon, 9-Nov 8:05 AM ET)
UPDATE - Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of HRK Healthcare LLC
Globe Newswire (Thu, 8-Oct 3:50 PM ET)
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of HRK Healthcare LLC
Globe Newswire (Thu, 8-Oct 2:10 PM ET)
Tevogen Regains Compliance with Nasdaq Global Market Continued Listing Requirements
Globe Newswire (Wed, 30-Sep 4:30 PM ET)
Tevogen - Warrant trades on the stock market under the symbol TVGNW.
As of November 13, 2026, TVGNW stock price declined to $0.04 with 307,168 million shares trading.
TVGNW has a beta of 0.50, meaning it tends to be less sensitive to market movements. TVGNW has a correlation of 0.00 to the broad based SPY ETF.
TVGNW has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
TVGNW has underperformed the market in the last year with a price return of -24.7% while the SPY ETF gained +13.4%. TVGNW has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -29.6% and -59.2%, respectively, while the SPY returned -2.8% and -0.2%, respectively.
TVGNW support price is $.03 and resistance is $.05 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TVGNW shares will trade within this expected range on the day.
